IDP Pharma raises 2,7M€ its first operative year.

important, news

IDP Pharma has closed a 1,4M€ seed investment round, following a pre-seed round of 0,1M€ (June 2015) , which adds to the 1,2M€ funds granted by several public institutions (MINECO, ENISA, CDTI-NEOTEC and ACCIÓ).

The company will allocate the capital to advance the preclinical development of its first products for two cancer indications, to set up new discovery programs, and to continue developing its technology: IDP-Platform.